InsiderTrades.com logo
The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way
From Smallcaps Daily   |   Ad
See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.
Click to read

BMRN Insider Trading

Insider Ownership Percentage: 1.85%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $18,170,424.76

BioMarin Pharmaceutical Insider Trading History Chart

This chart shows the insider buying and selling history at BioMarin Pharmaceutical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioMarin Pharmaceutical Share Price & Price History

Current Price: $81.83
Price Change: ▼ Price Decrease of -0.75 (-0.91%)
As of 05/8/2024 01:00 AM ET

This chart shows the closing price history over time for BMRN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way
From Smallcaps Daily   |   Ad
See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.
Click to read

BioMarin Pharmaceutical Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/2/2024George Eric DavisEVPSell1,850$85.01$157,268.5056,157View SEC Filing Icon  
4/12/2024Jean Jacques BienaimeDirectorSell20,000$91.26$1,825,200.00474,994View SEC Filing Icon  
4/10/2024Erin BurkhartCAOSell2,286$90.00$205,740.0016,156View SEC Filing Icon  
3/28/2024George Eric DavisEVPSell24,602$88.34$2,173,340.6855,856View SEC Filing Icon  
3/5/2024Henry J. FuchsInsiderSell35,341$85.18$3,010,346.38212,117View SEC Filing Icon  
3/5/2024Jean Jacques BienaimeDirectorSell1,000$85.51$85,510.00561,203View SEC Filing Icon  
3/5/2024Jeffrey Robert AjerEVPSell4,000$87.07$348,280.0094,047View SEC Filing Icon  
2/27/2024Jean Jacques BienaimeDirectorSell1,000$90.35$90,350.00562,203View SEC Filing Icon  
2/9/2024Jean Jacques BienaimeDirectorSell15,000$88.28$1,324,200.00419,602View SEC Filing Icon  
1/9/2024Jean Jacques BienaimeDirectorSell10,000$98.19$981,900.00425,162View SEC Filing Icon  
12/21/2023Jean Jacques BienaimeDirectorSell10,000$93.99$939,900.00425,112View SEC Filing Icon  
12/13/2023George Eric DavisEVPSell13,764$95.30$1,311,709.2055,710View SEC Filing Icon  
8/16/2023Jeffrey Robert AjerEVPSell5,000$90.00$450,000.0060,804View SEC Filing Icon  
8/10/2023Henry J. FuchsInsiderSell12,000$90.43$1,085,160.00176,187View SEC Filing Icon  
8/8/2023George Eric DavisEVPSell11,000$89.42$983,620.0069,474View SEC Filing Icon  
8/7/2023Jean Jacques BienaimeCEOSell4,000$88.10$352,400.00428,732View SEC Filing Icon  
5/10/2023Jean Jacques BienaimeCEOSell30,000$94.85$2,845,500.00426,213View SEC Filing Icon  
4/10/2023Jean Jacques BienaimeCEOSell10,000$99.56$995,600.00425,896View SEC Filing Icon  
4/6/2023Jean Jacques BienaimeCEOSell10,000$96.13$961,300.00425,896View SEC Filing Icon  
4/3/2023V. Bryan LawlisDirectorSell8,500$97.09$825,265.0028,950View SEC Filing Icon  
3/13/2023Jean Jacques BienaimeCEOSell8,000$90.45$723,600.00487,856View SEC Filing Icon  
3/10/2023Jean Jacques BienaimeCEOSell15,000$92.28$1,384,200.00487,856View SEC Filing Icon  
2/13/2023Jean Jacques BienaimeCEOSell6,000$109.15$654,900.00320,324View SEC Filing Icon  
2/10/2023Jean Jacques BienaimeCEOSell15,000$110.11$1,651,650.00320,324View SEC Filing Icon  
1/25/2023Jeffrey Robert AjerEVPSell49,000$115.70$5,669,300.0041,088View SEC Filing Icon  
1/17/2023Jean Jacques BienaimeCEOSell10,000$111.55$1,115,500.00320,424View SEC Filing Icon  
1/13/2023Brian R. MuellerCFOSell2,500$114.50$286,250.0027,746View SEC Filing Icon  
1/13/2023Jean Jacques BienaimeCEOSell10,000$112.25$1,122,500.00320,424View SEC Filing Icon  
12/13/2022Brian R. MuellerCFOSell2,500$107.50$268,750.0027,746View SEC Filing Icon  
12/13/2022Jean Jacques BienaimeCEOSell1,000$106.89$106,890.00320,424View SEC Filing Icon  
12/2/2022Brian R. MuellerCFOSell7,001$104.50$731,604.5027,746View SEC Filing Icon  
12/2/2022Jean Jacques BienaimeCEOSell1,500$103.98$155,970.00321,424View SEC Filing Icon  
11/23/2022Brian R. MuellerCFOSell5,379$98.73$531,068.6728,847View SEC Filing Icon  
11/2/2022Jeffrey Robert AjerEVPSell3,000$86.12$258,360.0041,088View SEC Filing Icon  
10/31/2022Jean Jacques BienaimeCEOSell1,500$86.55$129,825.00322,824View SEC Filing Icon  
10/31/2022Mark J. AllesDirectorBuy3,625$86.75$314,468.7510,905View SEC Filing Icon  
10/14/2022Jean Jacques BienaimeCEOSell4,000$89.89$359,560.00324,324View SEC Filing Icon  
8/15/2022Jean Jacques BienaimeCEOSell3,000$95.21$285,630.00328,324View SEC Filing Icon  
8/12/2022Jean Jacques BienaimeCEOSell4,000$94.75$379,000.00331,324View SEC Filing Icon  
8/11/2022Jeffrey Robert AjerEVPSell3,000$95.62$286,860.0044,088View SEC Filing Icon  
8/8/2022Charles Greg GuyerEVPSell6,205$96.56$599,154.8042,168View SEC Filing Icon  
7/8/2022Brian R. MuellerCFOSell7,337$89.50$656,661.5030,726View SEC Filing Icon  
7/8/2022George Eric DavisEVPSell7,398$90.00$665,820.0058,941View SEC Filing Icon  
5/26/2022Jeffrey Robert AjerEVPSell1,308$78.94$103,253.5254,109View SEC Filing Icon  
5/5/2022Jean Jacques BienaimeCEOSell10,000$84.14$841,400.00335,324View SEC Filing Icon  
5/4/2022Brian R. MuellerCFOSell11,800$84.50$997,100.0038,639View SEC Filing Icon  
5/2/2022George Eric DavisEVPSell15,347$80.38$1,233,591.8666,339View SEC Filing Icon  
5/2/2022Richard A. MeierDirectorSell3,878$82.09$318,345.02104,014View SEC Filing Icon  
4/28/2022Jean Jacques BienaimeCEOSell20,000$83.79$1,675,800.00334,983View SEC Filing Icon  
4/18/2022Jean Jacques BienaimeCEOSell20,000$81.91$1,638,200.00334,983View SEC Filing Icon  
4/14/2022Jean Jacques BienaimeCEOSell10,000$83.66$836,600.00334,983View SEC Filing Icon  
4/14/2022V. Bryan LawlisDirectorSell4,250$83.66$355,555.0023,970View SEC Filing Icon  
4/13/2022Jeffrey Robert AjerEVPSell1,180$82.47$97,314.6055,077View SEC Filing Icon  
3/29/2022Jeffrey Robert AjerEVPSell1,618$79.43$128,517.74View SEC Filing Icon  
3/23/2022Jeffrey Robert AjerEVPSell6,129$81.78$501,229.62View SEC Filing Icon  
3/21/2022George Eric DavisEVPSell6,129$81.29$498,226.41View SEC Filing Icon  
3/10/2022Jean Jacques BienaimeCEOSell15,000$77.57$1,163,550.00View SEC Filing Icon  
2/28/2022Dennis SlamonDirectorSell6,396$78.33$500,998.68View SEC Filing Icon  
1/14/2022V. Bryan LawlisDirectorSell4,250$87.61$372,342.50View SEC Filing Icon  
1/13/2022Jean Jacques BienaimeCEOSell5,000$87.86$439,300.00View SEC Filing Icon  
12/15/2021Jean Jacques BienaimeCEOSell6,000$82.71$496,260.00View SEC Filing Icon  
12/1/2021Jean Jacques BienaimeCEOSell1,500$87.22$130,830.00View SEC Filing Icon  
10/26/2021Jeffrey Robert AjerEVPSell2,739$73.60$201,590.40View SEC Filing Icon  
5/10/2021Jean Jacques BienaimeCEOSell8,513$77.29$657,969.77312,352View SEC Filing Icon  
5/7/2021Brian R. MuellerCFOSell6,709$79.50$533,365.5031,357View SEC Filing Icon  
5/7/2021Jean Jacques BienaimeCEOSell25,000$78.12$1,953,000.00303,839View SEC Filing Icon  
See Full Table
The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way
From Smallcaps Daily   |   Ad
See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.
Click to read

SEC Filings (Institutional Ownership Changes) for BioMarin Pharmaceutical (NASDAQ:BMRN)

98.71% of BioMarin Pharmaceutical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BMRN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

BioMarin Pharmaceutical Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/8/2024Motley Fool Asset Management LLC186,492$16.29M0.5%+322.7%0.098%Search for SEC Filing on Google Icon
5/8/2024Motley Fool Wealth Management LLC458,735$40.07M2.1%-2.5%0.242%Search for SEC Filing on Google Icon
5/8/2024ProShare Advisors LLC13,221$1.16M0.0%+9.8%0.007%Search for SEC Filing on Google Icon
5/8/2024Avantax Advisory Services Inc.3,411$0.30M0.0%N/A0.002%Search for SEC Filing on Google Icon
5/8/2024Russell Investments Group Ltd.64,826$5.68M0.0%-90.2%0.034%Search for SEC Filing on Google Icon
5/8/2024Qsemble Capital Management LP8,848$0.77M0.2%-9.8%0.005%Search for SEC Filing on Google Icon
5/8/2024Headlands Technologies LLC5,692$0.50M0.1%+344.3%0.003%Search for SEC Filing on Google Icon
5/7/2024Comgest Global Investors S.A.S.212,464$18.56M0.3%+6.6%0.112%Search for SEC Filing on Google Icon
5/7/2024Susquehanna Portfolio Strategies LLC39,949$3.49M0.1%-80.3%0.021%Search for SEC Filing on Google Icon
5/7/2024Swiss National Bank564,200$49.28M0.0%-4.1%0.297%Search for SEC Filing on Google Icon
5/7/2024Forsta AP Fonden36,300$3.17M0.0%+12.4%0.019%Search for SEC Filing on Google Icon
5/7/2024Oppenheimer & Co. Inc.4,714$0.41M0.0%+70.5%0.002%Search for SEC Filing on Google Icon
5/7/2024Mesirow Institutional Investment Management Inc.31,760$2.77M0.2%+8.5%0.017%Search for SEC Filing on Google Icon
5/7/2024Empowered Funds LLC2,383$0.21M0.0%N/A0.001%Search for SEC Filing on Google Icon
5/7/2024AIA Group Ltd4,076$0.36M0.0%+7.0%0.002%Search for SEC Filing on Google Icon
5/6/2024Envestnet Portfolio Solutions Inc.10,668$0.93M0.0%+1.2%0.006%Search for SEC Filing on Google Icon
5/6/2024Grandfield & Dodd LLC16,127$1.41M0.1%+1.6%0.008%Search for SEC Filing on Google Icon
5/3/2024GSA Capital Partners LLP7,035$0.61M0.0%N/A0.004%Search for SEC Filing on Google Icon
5/3/2024BI Asset Management Fondsmaeglerselskab A S5,723$0.50M0.0%-33.0%0.003%Search for SEC Filing on Google Icon
5/3/2024Central Pacific Bank Trust Division4,050$0.35M0.0%N/A0.002%Search for SEC Filing on Google Icon
5/2/2024FORA Capital LLC27,823$2.43M0.2%+26.5%0.015%Search for SEC Filing on Google Icon
5/2/2024Daiwa Securities Group Inc.16,307$1.42M0.0%-17.6%0.009%Search for SEC Filing on Google Icon
5/2/2024Nordea Investment Management AB13,675$1.21M0.0%+17.9%0.007%Search for SEC Filing on Google Icon
5/2/2024Tokio Marine Asset Management Co. Ltd.20,494$1.79M0.1%-3.2%0.011%Search for SEC Filing on Google Icon
5/1/2024Janney Montgomery Scott LLC8,422$0.74M0.0%-3.1%0.004%Search for SEC Filing on Google Icon
5/1/2024Mirae Asset Global Investments Co. Ltd.108,081$9.83M0.0%+110.7%0.057%Search for SEC Filing on Google Icon
4/30/2024Van ECK Associates Corp142,837$12.48M0.0%+6.5%0.076%Search for SEC Filing on Google Icon
4/30/2024Commonwealth Equity Services LLC7,290$0.64M0.0%+6.6%0.004%Search for SEC Filing on Google Icon
4/29/2024Principal Financial Group Inc.33,159$2.90M0.0%+11.6%0.018%Search for SEC Filing on Google Icon
4/29/2024Mn Services Vermogensbeheer B.V.31,700$2.77M0.0%-63.2%0.017%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.36,621$3.20M0.4%+65.3%0.019%Search for SEC Filing on Google Icon
4/26/2024Yousif Capital Management LLC2,414$0.21M0.0%+8.9%0.001%Search for SEC Filing on Google Icon
4/25/2024Fjarde AP Fonden Fourth Swedish National Pension Fund63,069$5.51M0.1%+3.8%0.033%Search for SEC Filing on Google Icon
4/25/2024Summit Financial LLC57,628$5.03M0.3%-1.6%0.031%Search for SEC Filing on Google Icon
4/24/2024Simplicity Wealth LLC2,958$0.26M0.0%N/A0.002%Search for SEC Filing on Google Icon
4/24/2024Assenagon Asset Management S.A.3,145$0.28M0.0%-81.5%0.002%Search for SEC Filing on Google Icon
4/23/2024Rice Hall James & Associates LLC28,722$2.51M0.1%-2.4%0.015%Search for SEC Filing on Google Icon
4/22/2024EFG Asset Management Americas Corp.19,816$1.73M0.5%-27.2%0.010%Search for SEC Filing on Google Icon
4/22/2024IFM Investors Pty Ltd38,328$3.35M0.0%+0.4%0.020%Search for SEC Filing on Google Icon
4/19/2024New Century Financial Group LLC2,871$0.25M0.2%-39.2%0.002%Search for SEC Filing on Google Icon
4/19/2024AMI Asset Management Corp346,189$30.24M1.5%+51.9%0.183%Search for SEC Filing on Google Icon
4/19/2024State of Alaska Department of Revenue21,095$1.84M0.0%-24.6%0.011%Search for SEC Filing on Google Icon
4/19/2024Sumitomo Mitsui Trust Holdings Inc.477,500$41.71M0.0%-0.9%0.253%Search for SEC Filing on Google Icon
4/18/2024Allspring Global Investments Holdings LLC100,279$8.76M0.0%+65.6%0.053%Search for SEC Filing on Google Icon
4/18/2024SteelPeak Wealth LLC2,498$0.22M0.0%+10.9%0.001%Search for SEC Filing on Google Icon
4/17/2024Cannon Global Investment Management LLC7,800$0.68M1.8%+11.4%0.004%Search for SEC Filing on Google Icon
4/16/2024New England Research & Management Inc.15,350$1.34M0.7%N/A0.008%Search for SEC Filing on Google Icon
4/16/2024Capital Insight Partners LLC2,390$0.21M0.0%N/A0.001%Search for SEC Filing on Google Icon
4/16/2024180 Wealth Advisors LLC2,893$0.25M0.0%-4.5%0.002%Search for SEC Filing on Google Icon
4/12/2024Gateway Investment Advisers LLC21,320$1.86M0.0%+65.2%0.011%Search for SEC Filing on Google Icon
4/11/2024Tealwood Asset Management Inc.12,201$1.07M0.5%-1.8%0.006%Search for SEC Filing on Google Icon
4/10/2024Park Avenue Securities LLC4,620$0.40M0.0%-25.5%0.002%Search for SEC Filing on Google Icon
4/10/2024Banque Cantonale Vaudoise16,350$1.43M0.1%-2.5%0.009%Search for SEC Filing on Google Icon
3/21/2024Healthcare of Ontario Pension Plan Trust Fund53,087$5.12M0.0%N/A0.028%Search for SEC Filing on Google Icon
3/11/2024Vanguard Group Inc.18,050,062$1.74B0.0%+2.0%9.566%Search for SEC Filing on Google Icon
3/11/2024Wahed Invest LLC3,191$0.31M0.1%+10.0%0.002%Search for SEC Filing on Google Icon
3/6/2024SageView Advisory Group LLC2,945$0.26M0.0%N/A0.002%Search for SEC Filing on Google Icon
3/5/2024Fisher Asset Management LLC13,490$1.30M0.0%N/A0.007%Search for SEC Filing on Google Icon
3/1/2024Royal London Asset Management Ltd.73,817$7.12M0.0%+2.7%0.039%Search for SEC Filing on Google Icon
2/26/2024Integrated Advisors Network LLC3,533$0.34M0.0%+6.2%0.002%Search for SEC Filing on Google Icon
2/26/2024Teachers Retirement System of The State of Kentucky163,798$15.79M0.1%-7.8%0.087%Search for SEC Filing on Google Icon
2/22/2024Scarborough Advisors LLC737$71K0.0%N/A0.000%Search for SEC Filing on Google Icon
2/20/2024Voisard Asset Management Group Inc.1,025$99K0.1%N/A0.001%Search for SEC Filing on Google Icon
2/20/2024Readystate Asset Management LP12,726$1.23M0.0%-22.4%0.007%Search for SEC Filing on Google Icon
2/16/2024Price T Rowe Associates Inc. MD1,605,983$154.85M0.0%+33.3%0.853%Search for SEC Filing on Google Icon
2/14/2024Third Point LLC385,000$37.12M0.6%N/A0.204%Search for SEC Filing on Google Icon
2/14/2024Iron Triangle Partners LP200,000$19.28M2.5%N/A0.106%Search for SEC Filing on Google Icon
2/14/2024Altitude Crest Partners Inc.114,042$11M7.4%N/A0.061%Search for SEC Filing on Google Icon
2/14/2024First Light Asset Management LLC185,579$17.89M1.4%+200.5%0.099%Search for SEC Filing on Google Icon
2/14/2024Frontier Capital Management Co. LLC442,456$42.66M0.4%+2.6%0.235%Search for SEC Filing on Google Icon
2/14/2024Bridgewater Associates LP190,970$18.41M0.1%+18.3%0.101%Search for SEC Filing on Google Icon
2/14/2024Artia Global Partners LP28,885$2.79M0.8%-63.2%0.015%Search for SEC Filing on Google Icon
2/14/2024Bellevue Group AG325,776$31.41M0.5%-6.9%0.173%Search for SEC Filing on Google Icon
2/14/2024Avoro Capital Advisors LLC4,300,000$414.61M5.7%+11.7%2.283%Search for SEC Filing on Google Icon
2/14/2024Lighthouse Investment Partners LLC40,613$3.92M0.2%N/A0.022%Search for SEC Filing on Google Icon
2/14/2024Scout Investments Inc.791,625$76.33M1.9%-12.3%0.420%Search for SEC Filing on Google Icon
2/14/2024Sectoral Asset Management Inc.50,070$4.83M2.1%-65.5%0.027%Search for SEC Filing on Google Icon
2/13/2024Morningstar Investment Services LLC44,602$4.33M0.0%+109.3%0.024%Search for SEC Filing on Google Icon
2/13/2024Pinebridge Investments L.P.23,189$2.24M0.0%+33.6%0.012%Search for SEC Filing on Google Icon
2/13/2024Cibc World Markets Corp270,242$26.06M0.1%N/A0.143%Search for SEC Filing on Google Icon
2/13/2024Gabelli Funds LLC7,175$0.69M0.0%-12.6%0.004%Search for SEC Filing on Google Icon
2/13/2024Public Employees Retirement Association of Colorado22,011$2.12M0.0%+5,430.4%0.012%Search for SEC Filing on Google Icon
2/13/20241832 Asset Management L.P.737,221$71.08M0.1%+55.7%0.391%Search for SEC Filing on Google Icon
2/13/2024Capital Research Global Investors10,774,641$1.04B0.3%+79.0%5.720%Search for SEC Filing on Google Icon
2/13/2024Eisler Capital UK Ltd.12,584$1.21M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/13/2024First Trust Advisors LP579,931$55.92M0.1%+10.8%0.308%Search for SEC Filing on Google Icon
2/13/2024Royal London Asset Management Ltd.73,817$7.12M0.0%+2.7%0.039%Search for SEC Filing on Google Icon
2/13/2024Rafferty Asset Management LLC96,599$9.31M0.0%-2.2%0.051%Search for SEC Filing on Google Icon
2/13/2024Rhenman & Partners Asset Management AB282,500$27.24M2.7%-25.7%0.150%Search for SEC Filing on Google Icon
2/13/2024CIBC Asset Management Inc6,034$0.58M0.0%-6.9%0.003%Search for SEC Filing on Google Icon
2/13/2024Jones Financial Companies Lllp450$43K0.0%N/A0.000%Search for SEC Filing on Google Icon
2/13/2024APG Asset Management US Inc.35,901$3.46M0.0%N/A0.019%Search for SEC Filing on Google Icon
2/13/2024California State Teachers Retirement System280,920$27.09M0.0%-1.2%0.149%Search for SEC Filing on Google Icon
2/12/2024Eagle Asset Management Inc.436,279$42.07M0.2%-0.4%0.232%Search for SEC Filing on Google Icon
2/12/2024Brown Brothers Harriman & Co.266$26K0.0%-69.3%0.000%Search for SEC Filing on Google Icon
2/12/2024Bank of Nova Scotia277,468$26.75M0.1%+1.7%0.147%Search for SEC Filing on Google Icon
2/12/2024Parnassus Investments LLC1,849,348$178.31M0.4%-20.9%0.982%Search for SEC Filing on Google Icon
2/12/2024Comgest Global Investors S.A.S.199,321$19.22M0.3%+12.6%0.106%Search for SEC Filing on Google Icon
2/12/2024TFO Wealth Partners LLC4,059$0.39M0.0%+912.2%0.002%Search for SEC Filing on Google Icon
2/12/2024Treasurer of the State of North Carolina104,083$10.04M0.0%+6.2%0.055%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BioMarin Pharmaceutical logo
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. The company's commercial products also comprise Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme, which is delivered through subcutaneous injection to reduce blood Phe concentrations; Brineura, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; Voxzogo, a once daily injection analog of c-type natriuretic peptide for the treatment of achondroplasia; and Aldurazyme, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase. In addition, it develops Roctavian, an adeno associated virus vector, for the treatment of patients with severe hemophilia A. The company serves specialty pharmacies, hospitals, and non-U.S. government agencies, as well as distributors and pharmaceutical wholesalers in the United States, Europe, Latin America, and internationally. BioMarin Pharmaceutical Inc. has license and collaboration agreements with Sarepta Therapeutics, Ares Trading S.A., Catalyst Pharmaceutical Partners, Inc. The company was incorporated in 1996 and is headquartered in San Rafael, California.
Read More on BioMarin Pharmaceutical

Today's Range

Now: $81.83
Low: $81.79
High: $83.19

50 Day Range

MA: $86.56
Low: $80.76
High: $92.22

52 Week Range

Now: $81.83
Low: $76.02
High: $99.56

Volume

1,288,621 shs

Average Volume

1,450,264 shs

Market Capitalization

$15.54 billion

P/E Ratio

76.48

Dividend Yield

N/A

Beta

0.34

Who are the company insiders with the largest holdings of BioMarin Pharmaceutical?

BioMarin Pharmaceutical's top insider shareholders include:
  1. Jean Jacques Bienaime (Director)
  2. Jean Jacques Bienaime (CEO)
  3. Henry J Fuchs (Insider)
  4. Jeffrey Robert Ajer (EVP)
  5. George Eric Davis (EVP)
  6. Charles Greg Guyer (EVP)
  7. Brian Mueller (CFO)
  8. V Bryan Lawlis (Director)
  9. Erin Burkhart (CAO)
  10. Mark J Alles (Director)
Learn More about top insider investors at BioMarin Pharmaceutical.

Who are the major institutional investors of BioMarin Pharmaceutical?

BioMarin Pharmaceutical's top institutional investors include:
  1. Swiss National Bank — 0.30%
  2. Sumitomo Mitsui Trust Holdings Inc. — 0.25%
  3. Motley Fool Wealth Management LLC — 0.24%
  4. AMI Asset Management Corp — 0.18%
  5. Comgest Global Investors S.A.S. — 0.11%
  6. Motley Fool Asset Management LLC — 0.10%
Learn More about top institutional investors of BioMarin Pharmaceutical stock.

Which major investors are selling BioMarin Pharmaceutical stock?

During the previous quarter, BMRN stock was sold by these institutional investors:
  1. Russell Investments Group Ltd.
  2. Susquehanna Portfolio Strategies LLC
  3. Mn Services Vermogensbeheer B.V.
  4. Swiss National Bank
  5. Assenagon Asset Management S.A.
  6. Motley Fool Wealth Management LLC
  7. EFG Asset Management Americas Corp.
  8. State of Alaska Department of Revenue
During the previous year, company insiders that have sold BioMarin Pharmaceutical company stock include:
  1. Jean Jacques Bienaime (Director)
  2. Jean Jacques Bienaime (CEO)
  3. Henry J Fuchs (Insider)
  4. Jeffrey Robert Ajer (EVP)
  5. George Eric Davis (EVP)
  6. Charles Greg Guyer (EVP)
Learn More investors selling BioMarin Pharmaceutical stock.

Which major investors are buying BioMarin Pharmaceutical stock?

During the last quarter, BMRN stock was bought by institutional investors including:
  1. Motley Fool Asset Management LLC
  2. AMI Asset Management Corp
  3. Mirae Asset Global Investments Co. Ltd.
  4. Allspring Global Investments Holdings LLC
  5. New England Research & Management Inc.
  6. China Universal Asset Management Co. Ltd.
  7. Comgest Global Investors S.A.S.
  8. Van ECK Associates Corp
The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way
From Smallcaps Daily   |   Ad
See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.
Click to read